MedTrace Logo

TCB Self-Monitoring in Healthy Term and Near-Term Neonates

NCT06645158 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220950

Last updated 2025-09-11

No results posted yet for this study

Summary

The goal of this observational study is to monitor the transcutaneous bilirubin (TCB) level in healthy near-term and full-term neonates from birth to 30 days of age across China. The main question it aims to answer is:

Development of TcB Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants Compare the changing trend of TCB among different areas in China Compare the changing trend of TCB among different gestational groups in China

Conditions

  • Hyperbilirubinemia, Neonatal

Interventions

DEVICE

Transcutaneous bilirubin level monitoring

self-monitoring by parents long-term: from birth to 30 days of age

Sponsors & Collaborators

  • Guangzhou Women and Children's Medical Center

    collaborator OTHER

  • Neonatal-Infant Brain and Behavior Development Network

    lead NETWORK

Eligibility

Min Age
0 Days
Max Age
30 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2024-12-31
Completion
2025-07-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06645158 on ClinicalTrials.gov